BE905911A - Lysat antigene bacterien, procede de preparation et compositions pharmaceutiques en contenant. - Google Patents

Lysat antigene bacterien, procede de preparation et compositions pharmaceutiques en contenant.

Info

Publication number
BE905911A
BE905911A BE0/217521A BE217521A BE905911A BE 905911 A BE905911 A BE 905911A BE 0/217521 A BE0/217521 A BE 0/217521A BE 217521 A BE217521 A BE 217521A BE 905911 A BE905911 A BE 905911A
Authority
BE
Belgium
Prior art keywords
bacterial antigen
preparation
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
BE0/217521A
Other languages
English (en)
Inventor
Giuseppe Monti
Monti Giuseppe
Original Assignee
Belfanti Ist Sieroterap Milan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belfanti Ist Sieroterap Milan filed Critical Belfanti Ist Sieroterap Milan
Publication of BE905911A publication Critical patent/BE905911A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Lysat antigène bactérien préparé en soumettant à une lyse des souches bactériennes choisies, en particulier de Straphylococcus aureus, Streptococcus pyogenes, Streptoccus viridans, Diplococcus pneumoniae, Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae type B, Neiseria catarrhalis, les lysats obtenus étant utiles comme vaccins administrés par voie orale dans le traitement de formes infectieuses des voies respiratoires et en particulier dans la prévention de la récidive et du passage à l'état chronique.
BE0/217521A 1986-11-21 1986-12-12 Lysat antigene bacterien, procede de preparation et compositions pharmaceutiques en contenant. BE905911A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48677/86A IT1199301B (it) 1986-11-21 1986-11-21 Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (1)

Publication Number Publication Date
BE905911A true BE905911A (fr) 1987-04-01

Family

ID=11267997

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217521A BE905911A (fr) 1986-11-21 1986-12-12 Lysat antigene bacterien, procede de preparation et compositions pharmaceutiques en contenant.

Country Status (7)

Country Link
EP (1) EP0269928A3 (fr)
JP (1) JPS63233929A (fr)
BE (1) BE905911A (fr)
DE (1) DE269928T1 (fr)
ES (1) ES2005057A4 (fr)
GR (1) GR880300141T1 (fr)
IT (1) IT1199301B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509817B1 (ko) * 1997-06-27 2005-12-16 씨제이 주식회사 비브리오불니피쿠스의감염예방을위한경구용백신
WO2004112833A1 (fr) 2003-06-23 2004-12-29 Biotech Tools Sa Composition d'epitope pour administration par voie sublinguale, buccale ou enterale, obtenue par hydrolyse de structures antigeniques a l'aide de chymotrypsine
US20090297561A1 (en) * 2003-09-03 2009-12-03 Intralytix Method for vaccination of poultry by bacteriophage lysate bacterin
SI2114421T1 (en) 2007-03-05 2018-04-30 Om Pharma A bacterial extract for respiratory disorders and a process for its preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792256C3 (de) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
DE3581091D1 (de) * 1984-03-09 1991-02-07 Advance Kk Anti-karies- oder anti-periodontitismittel.
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.

Also Published As

Publication number Publication date
GR880300141T1 (en) 1988-12-16
DE269928T1 (de) 1988-11-03
EP0269928A3 (fr) 1990-02-07
ES2005057A4 (es) 1989-03-01
EP0269928A2 (fr) 1988-06-08
IT8648677A0 (it) 1986-11-21
JPS63233929A (ja) 1988-09-29
IT1199301B (it) 1988-12-30

Similar Documents

Publication Publication Date Title
Lassen Yersinia enterocolitica in drinking-water
WEISER et al. Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial
Greisman et al. Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone
Cryz Jr et al. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice
Layman et al. Growth inhibitory effects of endotoxins from Bacteroides gingivalis and intermedius on human gingival fibroblasts in vitro
Trümpler et al. Antibacterial prophylaxis with lactoferrin in neutropenic patients
Poirier Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia
BE905911A (fr) Lysat antigene bacterien, procede de preparation et compositions pharmaceutiques en contenant.
Brook et al. Acute suppurative parotitis caused by anaerobic bacteria: report of two cases
Kennedy et al. Effects on monkeys of introduction of hemolytic streptococci into root canals
Ginsburg et al. Clinical pharmacology of cefadroxil in infants and children
Helderman et al. A selective medium for the two major subgroups of the bacterium Streptococcus mutans isolated from human dental plaque and saliva
St John et al. Eikenella corrodens empyema in children
KR910015306A (ko) 피부염 치료용 약제
Toshniwal et al. Manifestations of Kingella kingae infections in adults: resemblance to neisserial infections
Brook et al. Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B. ruminicola subsp. brevis in abscesses in mice
Azimi Clinical and laboratory investigation of cefamandole therapy of infections in infants and children
FR2426470A1 (fr) Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
Franzén et al. Trimethoprim-sulphamethoxazole in enteric infections
Dul et al. EF-4 bacteremia in a patient with hepatic carcinoid
Lewis et al. Kingella kingae causing septic arthritis in Felty’s syndrome
Henning et al. Studies of absorption, excretion, antibacterial and clinical effect of cephalexin
Mohan et al. Phenotype and serotype of Pasteurella multocida isolates from diseases of dogs and cats in Zimbabwe
Carson et al. Clinical trial of cefuroxime axetil in children
Hovelius et al. Respiratory tract infections at a community care centre—with emphasis on group A streptococci

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ISTITUTO SIEROTERAPICO MILANESE ''S. BELFANTI

Effective date: 19991231